Inflammation drives alternative first exon usage to regulate immune genes including a novel iron-regulated isoform of Aim2
Mouse
immunology
Mice
2.1 Biological and endogenous factors
Innate
genetics
Aetiology
Biology (General)
Promoter Regions, Genetic
Cells, Cultured
0303 health sciences
Cultured
Q
R
Genomics
Exons
3. Good health
DNA-Binding Proteins
Medicine
570
QH301-705.5
1.1 Normal biological development and functioning
Cells
Science
Immunology
Promoter Regions
splicing
03 medical and health sciences
Genetic
Underpinning research
Genetics
genomics
Animals
Humans
human
mouse
Inflammation
Inflammatory and immune system
Gene Expression Profiling
Macrophages
Human Genome
Immunity
Genetics and Genomics
Immunity, Innate
Alternative Splicing
inflammation
Biochemistry and Cell Biology
5' Untranslated Regions
Transcriptome
DOI:
10.7554/elife.69431
Publication Date:
2021-05-28T12:02:06Z
AUTHORS (13)
ABSTRACT
Determining the layers of gene regulation within the innate immune response is critical to our understanding of the cellular responses to infection and dysregulation in disease. We identified a conserved mechanism of gene regulation in human and mouse via changes in alternative first exon (AFE) usage following inflammation, resulting in changes to the isoforms produced. Of these AFE events, we identified 95 unannotated transcription start sites in mice using a de novo transcriptome generated by long-read native RNA-sequencing, one of which is in the cytosolic receptor for dsDNA and known inflammatory inducible gene,Aim2. We show that this unannotated AFE isoform ofAim2is the predominant isoform expressed during inflammation and contains an iron-responsive element in its 5′UTR enabling mRNA translation to be regulated by iron levels. This work highlights the importance of examining alternative isoform changes and translational regulation in the innate immune response and uncovers novel regulatory mechanisms ofAim2.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (114)
CITATIONS (26)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....